Carbimazole 20mg tablets

Land: Storbritannien

Språk: engelska

Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiva substanser:

Carbimazole

Tillgänglig från:

Advanz Pharma

ATC-kod:

H03BB01

INN (International namn):

Carbimazole

Dos:

20mg

Läkemedelsform:

Oral tablet

Administreringssätt:

Oral

Klass:

No Controlled Drug Status

Receptbelagda typ:

Valid as a prescribable product

Produktsammanfattning:

BNF: 06020200; GTIN: 5060337260091

Produktens egenskaper

OBJECT 1
CARBIMAZOLE 20 MG TABLETS
Summary of Product Characteristics Updated 20-Apr-2021 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Carbimazole 20 mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 20 mg of carbimazole.
Excipients with known effect:
Lactose Anhydrous (125.35 mg per tablet)
For a full list of excipients see section 6.1.
3. Pharmaceutical form
Pale pink, uncoated, round, biconvex tablets marked with LINK C20 on
one side and a scoreline on the
reverse.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Carbimazole is an anti-thyroid agent. It is indicated in adults and
children in all conditions where reduction
of thyroid function is required.
Such conditions are:
1. Hyperthyroidism.
2. Preparation for thyroidectomy in hyperthyroidism.
3. Therapy prior to and post radio-iodine treatment.
4.2 Posology and me